MARKET

ATHE

ATHE

Alterity Therapeutics Ltd
NASDAQ
4.390
-0.410
-8.54%
Closed 16:05 05/12 EDT
OPEN
4.850
PREV CLOSE
4.800
HIGH
4.850
LOW
4.350
VOLUME
41.22K
TURNOVER
0
52 WEEK HIGH
5.87
52 WEEK LOW
1.001
MARKET CAP
66.78M
P/E (TTM)
-2.9197
1D
5D
1M
3M
1Y
5Y
1D
Alterity Therapeutics has several presentations featured at 2025 MSA Congress
TipRanks · 20h ago
Alterity Therapeutics Presents MSA Research At 2025 International MSA Congress; ATH434 Phase 2 Data Shows Clinically Meaningful Efficacy On Multiple Clinical Endpoints
Benzinga · 20h ago
Weekly Report: what happened at ATHE last week (0505-0509)?
Weekly Report · 21h ago
Alterity Therapeutics Prominently Featured at the International MSA Congress
Barchart · 1d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 5d ago
Alterity Therapeutics management to meet with Maxim
TipRanks · 5d ago
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
Barchart · 6d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 05/05 17:05
More
About ATHE
More
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.
Recently
Symbol
Price
%Change

Webull offers Alterity Therapeutics Ltd (ADR) stock information, including NASDAQ: ATHE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATHE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATHE stock methods without spending real money on the virtual paper trading platform.